Doctor profile · Federal record

Dr. Antony Hou, M.D.

Rheumatology Physician (CMS: Rheumatology) · Specialist · Upland, CA

  • NPI 1114926367
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 22 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1238 E Arrow Hwy
Upland, CA 917864951
(909) 982-0099
fax (909) 931-0402

Credentials & registration

NPPES · NUCC
NPI registered
July 2005 — 21 yrs on file
Profile last updated
January 18, 2023
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #A73744
Medicaid
CA #GR0091870

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1114926367. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
219,865
Distinct HCPCS
10
Medicare allowed
$2,462,475
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 135,200 39 $5
J3111 Injection, romosozumab-aqqg, 1 mg 20,790 17 $10
J1602 Injection, golimumab, 1 mg, for intravenous use 17,170 19 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 11,950 18 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 8,474 26 $30
J0897 Injection, denosumab, 1 mg 6,360 67 $23
96372 Injection of drug or substance under skin or into muscle 2,230 331 $15
J9250 Methotrexate sodium, 5 mg 2,028 22 $0
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,837 183 $1
86235 Measurement of antibody for assessment of autoimmune disorder, any method 1,288 148 $18

In context: peer comparison

Among 1 peers in Upland Rheumatology Physician, average services per provider: 3,233. This provider delivers 68× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,300
Transactions
86
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Amgen INC. 27 $634.68
US Oncology Corporate, INC. 4 $621.57
Ucb, INC. 11 $218.75
GlaxoSmithKline, LLC. 10 $175.57
Novartis Pharmaceuticals Corporation 11 $155.10
Abbvie INC. 11 $130.83
AstraZeneca Pharmaceuticals Lp 1 $121.82
Pfizer INC. 4 $92.20
Ani Pharmaceuticals, INC. 2 $53.03
Janssen Biotech, INC. 2 $49.40
Boehringer Ingelheim Pharmaceuticals, INC. 1 $19.18
Sandoz INC. 1 $14.43
Scilex Pharmaceuticals INC. 1 $13.44

By nature of payment

Food and Beverage
$2,300

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,320
Patients
336
Total drug cost
$356,624
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 235 63 $10,998
Prednisone Generic 203 57 $1,472
Duloxetine Hcl Generic 173 47 $6,669
Methotrexate (Methotrexate Sodium) Brand 165 42 $8,450
Leucovorin Calcium Generic 97 34 $3,967
Diclofenac Sodium Generic 80 31 $6,735
Sulfasalazine Dr (Sulfasalazine) Brand 60 17 $2,161
Leflunomide Generic 58 18 $3,370
Gabapentin Generic 46 14 $1,235
Meloxicam Generic 44 13 $364

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Antony Hou's medical specialty?
Dr. Antony Hou practices Rheumatology Physician in Upland, CA.
Where does Dr. Antony Hou practice?
Dr. Antony Hou practices at 1238 E Arrow Hwy, Upland, CA 917864951. Office phone: 9099820099.
What is Dr. Antony Hou's NPI?
Dr. Antony Hou's National Provider Identifier (NPI) is 1114926367, issued by NPPES.
Does Dr. Antony Hou accept Medicare assignment?
Yes. Dr. Antony Hou accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Antony Hou commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.